AbbVie

Pharma TV ad spenders blow up December with spendiest month of 2020
Pharma TV ad spenders blow up December with spendiest month of 2020
Fierce Pharma
television ads
AbbVie
Humira
Novo Nordisk
DTC ads
Flag link:
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
Endpoints
AbbVie
Humira
psoriatic arthritis
Skyrizi
Flag link:
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
Fierce Biotech
AbbVie
Allergan
M&A
Sosei
Flag link:
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Fierce Pharma
drug pricing
Pfizer
AbbVie
Teva Pharmaceutical
Sanofi
Gilead Sciences
Flag link:
Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox
Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox
Biopharma Reporter
Aji Biopharma
ReVance
drug manufacturing
aesthetics
daxiabotulinumtoxinA
Botox
Allergan
AbbVie
Flag link:
AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft
AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft
Fierce Pharma
AbbVie
Allergan
Botox
ITC
Evolus
Jeuveau
Flag link:
AbbVie's Covid-19 antibody partner wraps $221M Hong Kong IPO
AbbVie's Covid-19 antibody partner wraps $221M Hong Kong IPO
Endpoints
AbbVie
Harbour BioMed
IPOs
Hong Kong
Flag link:
AbbVie pulls the trigger on a Covid-19 antibody, going all in on a drug discovered by research alliance
AbbVie pulls the trigger on a Covid-19 antibody, going all in on a drug discovered by research alliance
Endpoints
AbbVie
COVID-19
antibodies
Flag link:
AbbVie's Hopes of Replacing Humira Sales with Rinvoq Gains Momentum for Ulcerative Colitis
AbbVie's Hopes of Replacing Humira Sales with Rinvoq Gains Momentum for Ulcerative Colitis
BioSpace
AbbVie
Rinvoq
ulcerative colitis
clinical trials
Flag link:
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
AbbVie
Allergan
Humira
Rinvoq
Flag link:
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
Fierce Pharma
AstraZeneca
BeiGene
JNJ
AbbVie
Calquence
Brukinsa
Imbruvica
CLL
ASH2020
Flag link:
AbbVie pays Frontier $55M to pursue hard-to-drug targets
AbbVie pays Frontier $55M to pursue hard-to-drug targets
Fierce Biotech
AbbVie
Frontier Medicines
drug development
Flag link:
How AbbVie Beat Expectations in Q3
How AbbVie Beat Expectations in Q3
Motley Fool
AbbVie
earnings
Humira
Flag link:
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Allergan
AbbVie
presbyopia
clinical trials
AGN-190584
Flag link:
AbbVie’s Allergan Aesthetics brand gets a facelift
AbbVie’s Allergan Aesthetics brand gets a facelift
Fierce Pharma
AbbVie
Allergan
aesthetics
branding
Flag link:
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
Pharmaforum
Roche
Genentech
AbbVie
Venclexta
AML
clinical trials
FDA
Flag link:
4 AbbVie brands land on pharma's top TV spenders list for September
4 AbbVie brands land on pharma's top TV spenders list for September
Fierce Pharma
television ads
DTC ads
AbbVie
Humira
Skyrizi
Rinvoq
Ubrelvy
Flag link:
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Fierce Pharma
Ironwood
AbbVie
Linzess
IBS-C
FDA
Flag link:
Oxford University to test AbbVie's Humira as COVID-19 treatment
Oxford University to test AbbVie's Humira as COVID-19 treatment
Beckers Hospital Review
AbbVie
Humira
University of Oxford
clinical trials
COVID-19
Flag link:
Myovant shows disappointing prostate cancer data on the way to the FDA, stock sinks
Myovant shows disappointing prostate cancer data on the way to the FDA, stock sinks
Endpoints
Myovant
Relugolix
prostate cancer
AbbVie
Lupron
clinical trials
Flag link:

Pages